Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China.
Front Med
; 18(4): 752-756, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-39012398
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Front Med
/
Front. Med. (Online)
/
Frontiers of Medicine (Online)
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
China